Clinical Trial Update: A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

A first-in-human Phase 1 study to evaluate the safety and tolerability of VVD-159642 in participants with solid tumors; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• VVD-159642

Snippet

Sponsor: Vividion Therapeutics, Inc. | Conditions: Advanced Solid Tumors | Phase 1 | Status: RECRUITING